Brennan 2005
Identification of bioactive metabolites using activity metabolomics
Firstly, whilst most current LRAs can upregulate transcription initiation, few if any, are able to overcome the subsequent blocks to transcription elongation, completion and splicing ( Tat structure and function Tat is a small, basic protein of about 14-16 kDa, which is encoded by two exons that are alternatively spliced to become a full-length protein ( 101 ) ( 86 variant ( 72 ) such that it can function independently of the second coding exon ( 49 RKKRRQRRR 57 ) ( 72 , the second coding exon plays a role in the control of HIV transcription in CD4+ T cells by kappa-light-chain enhancer of activated B cells (NF-B) ( 73 RGD 75 motif which allows for interactions with cell surface molecules, triggering intracellular signaling cascades ( HIV transcription is driven by the Tat protein, which amplifies expression from the viral promoter within the HIV LTR ( Figure 1 ) ( Figure 1 Mechanisms of Tat secretion and uptake Tat secretion occurs via an unconventional secretion pathway ( 2 ), a phospholipid component of the inner leaflet of the plasma membrane ( Figure 2 ) ( Figure 2 Tat also contains a protein transduction domain which allows it to penetrate cells from the extracellular environment ( Tat secretion and systemic distribution in vivo Tat can be secreted from cells, potentially resulting in its dissemination throughout the circulation to multiple cell types and tissues ( Tat expression in the central nervous system (CNS) could be from HIV DNA+ cells in the brain, or via the trafficking of Tat protein from the periphery across the blood brain barrier ( Tat-related toxicities Many studies have shown differential expression of genes and proteins in cells after Tat treatment [reviewed in ( Tat concentrations as low as 10-15 ng/mL in the sera produce significant biological effects such as DNA damage in B cells, contributing to an increased risk of Burkitts lymphoma in PWH ( Tat as a potent, HIV-specific latency reversing agent Initial studies using transfection of a Tat expression plasmid resulted in weak viral reactivation in a latently infected cell line ( trans could result in efficient HIV reactivation, and thus Tat may represent a highly potent and specific latency reversing agent ( Recombinant Tat protein Recent work demonstrated that a truncated Tat variant comprising 66 amino acids (T66) was found to have comparable transactivation activity to both Tat 72 and Tat 86 in HEK293T cells expressing LTR-driven reporter plasmids ( in vitro model of HIV infection and in CD4+ T cells from PWH on ART, similar to positive controls that activated the T-cell, including Phorbol myristate acetate (PMA), phytohemagglutinin (PHA) and anti-CD3/anti-CD28 stimulation ( The ability of T66 protein to work equal to - or better than - the current gold-standards for latency reversal in vitro with few off-target effects highlights its promise as an LRA candidate
Of the 3 lipid peroxidation inhibitors, only NAC prevented LLP
We performed a microbial Genome Wide-Association Study (mGWAS) at both gene and SNP level
In conclusion, despite the clearly apparent therapeutic potential of MTs, their role is convoluted and context-dependent
